Kaisa Health FY26 H1 net loss widens to HK$ 62.48 million; revenue falls to HK$ 284.59 million

• Kaisa Health posted a net loss of HK$62.48 million for the six months ended June 30, swinging from profit a year earlier.
• Revenue fell 15.85% to HK$284.59 million, while loss per share narrowed to 1.24 HK cents.
• Loss before income tax widened to HK$67.18 million as other income, gains and losses turned to a HK$9.11 million loss.
• Cash dropped to HK$33.37 million, while net current liabilities widened to HK$669.07 million.
• Pharmaceutical revenue led at HK$219.85 million; the group completed the Embrace Blossom acquisition on June 24 under common control merger accounting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12299270), on August 25, 2026, and is solely responsible for the information contained therein.